-
Community Oncology Alliance Releases a Comprehensive Legislative Framework for Health Care Reform
The Community Oncology Alliance (COA) announced today the release of the COA Prescription for Health Care Reform, a comprehensive blueprint that diagnoses the fundamental challenges facing our health care system, outlines the consequences for patients across America, and presents actionable solutions that Congress must act on now to address these urgent issues.
-
Community Oncology Alliance Applauds Senate HELP Committee Report Exposing 340B Abuses
The Community Oncology Alliance applauds U.S. Senator Bill Cassidy, M.D. (R-LA), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee for releasing a comprehensive report detailing how large hospital systems have exploited the 340B Drug Pricing Program.
-
Analysis: Oncologists Could Face Over $12 Billion Cut in Medicare and Commercial Part B Payments Due to IRA Negotiations
A new analysis shows that physicians could lose at least $25 billion in add-on payments across both Medicare and the commercial market through the end of 2032 for the first 10 Part B drugs that may be negotiated under the Inflation Reduction Act (IRA).
-
Community Oncology Alliance Releases Quality and Value Standards in Cancer Care
The Community Oncology Alliance (COA) announced today the release of a set of Quality and Value Standards for cancer care. The Standards serve as a foundation for practices who wish to ensure the provision of high-quality care, participate in certification programs, as well as discuss and demonstrate what quality care is with patients, employers, and other payers. They were released today at COA’s annual Payer Exchange Summit on Oncology Payment Reform.
